Temas de la conferencia Built with biopharmaceutical industry insights, this meeting will unite KOLs from Europe and the rest of the world to delve into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines and therapeutics with improved specificity, delivery and efficacy for immuno-oncology, infectious diseases and beyond.
